Feasibility of an 8-item questionnaire for early diagnosis of inflammatory bowel disease in primary care

被引:10
作者
Chmiel, Corinne [1 ,2 ]
Vavricka, Stephan R. [3 ]
Hasler, Susann [1 ,2 ]
Rogler, Gerhard [3 ]
Zahnd, Nadine [3 ]
Schiesser, Salome [1 ,2 ]
Tandjung, Ryan [1 ,2 ]
Scherz, Nathalie [1 ,2 ]
Rosemann, Thomas [1 ,2 ]
Senn, Oliver [1 ,2 ]
机构
[1] Univ Zurich, Inst Primary Care, Zurich, Switzerland
[2] Univ Hosp Zurich, Zurich, Switzerland
[3] Univ Hosp Zurich, Dept Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland
关键词
calprotectin; Crohn's disease; diagnostic delay; early diagnosis; feasibility; general practitioner; inflammatory bowel disease; primary care; ulcerative colitis; FECAL CALPROTECTIN; ULCERATIVE-COLITIS; CROHNS-DISEASE; BLOOD LEUKOCYTES; MARKER; PERFORMANCE; ACCURACY; SYMPTOMS; REASONS; INDEX;
D O I
10.1111/jep.13046
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Aims Diagnosis of inflammatory bowel disease (IBD) is often associated with a diagnostic delay. Although faecal calprotectin is a helpful screening tool, the widespread use in primary care (PC) may not be appropriate due to the low prevalence of IBD in this setting. To increase pretest probability for a positive calprotectin test, an 8-item questionnaire (CalproQuest) was tested for its feasibility and acceptability in PC. Methods Population: PC patients with unspecific gastrointestinal complaints for at least 2 weeks. The CalproQuest consists of four major and four minor questions specific for IBD. It is considered positive if greater than or equal to two major or one major and two minor criteria are positive. Primary outcome: feasibility of CalproQuest, secondary outcome: patient's acceptance of stool sampling. Results Of 95 patients with a complete CalproQuest 52 (54.7%) were positive, 39 (41.1%) fulfilled two major and 13 (13.7%) one major and greater than or equal to two minor criteria. Twenty-seven general practitioners completed 83 (87.4%) questionnaires on feasibility which was assessed positive. Eighty-two patients (86.3%) completed questionnaires on acceptance which was high. Conclusion The CalproQuest is a feasible instrument for assessing IBD in PC. Further prospective studies concerning validity and cost effectiveness of a combined use with the calprotectin test in this setting are necessary.
引用
收藏
页码:155 / 162
页数:8
相关论文
共 33 条
[1]  
[Anonymous], NIH PUBLICATION, V94-1447
[2]  
[Anonymous], 2009, IRR BOW SYNDR GLOB P
[3]   Is irritable bowel syndrome a low-grade inflammatory bowel disease? [J].
Bercik, P ;
Verdu, EF ;
Collins, SM .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2005, 34 (02) :235-+
[4]   The FIRE project A milestone for research in primary care in Switzerland [J].
Chmiel, Corinne ;
Bhend, Heinz ;
Senn, Oliver ;
Zoller, Marco ;
Rosemann, Thomas .
SWISS MEDICAL WEEKLY, 2011, 141
[5]   Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease [J].
Costa, F ;
Mumolo, MG ;
Ceccarelli, L ;
Bellini, M ;
Romano, MR ;
Sterpi, C ;
Ricchiuti, A ;
Marchi, S ;
Bottai, M .
GUT, 2005, 54 (03) :364-368
[6]   Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease [J].
D'Haens, Geert ;
Ferrante, Marc ;
Vermeire, Severine ;
Baert, Filip ;
Noman, Maja ;
Moortgat, Liesbeth ;
Geens, Patricia ;
Iwens, Doreen ;
Aerden, Isolde ;
Van Assche, Gert ;
Van Olmen, Gust ;
Rutgeerts, Paul .
INFLAMMATORY BOWEL DISEASES, 2012, 18 (12) :2218-2224
[7]   Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative [J].
Danese, Silvio ;
Fiorino, Gionata ;
Mary, Jean-Yves ;
Lakatos, Peter L. ;
D'Haens, Geert ;
Moja, Lorenzo ;
D'Hoore, Andre ;
Panes, Julian ;
Reinisch, Walter ;
Sandborn, William J. ;
Travis, Simon P. ;
Vermeire, Severine ;
Peyrin-Biroulet, Laurent ;
Colombel, Jean-Frederic .
JOURNAL OF CROHNS & COLITIS, 2015, 9 (08) :601-606
[8]   VAlidation of an 8-item-questionnaire predictive for a positive caLprotectin tEst and Real-life implemenTation in primary care to reduce diagnostic delay in inflammatory bowel disease (ALERT): protocol for a prospective diagnostic study [J].
Hasler, Susann ;
Zahnd, Nadine ;
Mueller, Salome ;
Vavricka, Stephan ;
Rogler, Gerhard ;
Tandjung, Ryan ;
Rosemann, Thomas .
BMJ OPEN, 2015, 5 (03)
[9]   Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study [J].
Holtman, Gea A. ;
Lisman-van Leeuwen, Yvonne ;
Kollen, Boudewijn J. ;
Norbruis, Obbe F. ;
Escher, Johanna C. ;
Kindermann, Angelika ;
de Rijke, Yolanda B. ;
van Rheenen, Patrick F. ;
Berger, Marjolein Y. .
ANNALS OF FAMILY MEDICINE, 2016, 14 (05) :437-445
[10]   Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example [J].
Holtman, Gea A. ;
Lisman-van Leeuwen, Yvonne ;
Kollen, Boudewijn J. ;
Escher, Johanna C. ;
Kindermann, Angelika ;
van Rheenen, Patrick F. ;
Berger, Marjolein Y. .
BMC FAMILY PRACTICE, 2013, 14